ישראל -
עברית -
Ministry of Health
רנוולה אבקה 2.4 גרם
sanofi israel ltd - sevelamer carbonate anhydrous - אבקה להכנת תרחיף - sevelamer carbonate anhydrous 2.4 g/sachet - sevelamer - sevelamer - for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.also indicated for the control of hyperphosphataemia in adult patients with chronic kidney diseasenot on dialysis with serum phosphorus ? 1.78 mmol/l.should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.
ישראל -
עברית -
Ministry of Health
פונגימון
trima israel pharmaceutical products maabarot ltd - aluminium chlorohydrate; undecenoic acid; zinc undecenoate - אבקה - undecenoic acid 3 g / 100 g; aluminium chlorohydrate 3 g / 100 g; zinc undecenoate 18 g / 100 g - other antifungals for topical use - for prophylaxis and treatment of fungal infections of the skin especially "athletes foot".
ישראל -
עברית -
Ministry of Health
אנשור פלוס בטעם וניל ותות
abbott medical laboratories ltd - acid casein 4.4 g / 100 ml; ascorbic acid 35.3 mg / 100 ml - liquid - fat/carbohydrates/proteins/minerals/vitamins, combinations - for complete and balanced oral nutritional supplement that can be used with or between meals or in appropriate amounts, as a meal replacement.
ישראל -
עברית -
Ministry of Health
אנשור פלוס קפה
abbott medical laboratories ltd - ascorbic acid 15 mg / 100 ml; biotin 32 mcg / 100 ml - liquid - fat/carbohydrates/proteins/minerals/vitamins, combinations - for complete and balanced oral nutritional supplement that can be used with or between meals or in appropriate amounts, as a meal replacement.
ישראל -
עברית -
Ministry of Health
טייקרב
novartis israel ltd - lapatinib as ditosylate monohydrate - טבליות מצופות פילם - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting (see section 5.1).• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.